Page last updated: 2024-09-03

nitisinone and BH4 Deficiency

nitisinone has been researched along with BH4 Deficiency in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Heiner-Fokkema, MR; Lubout, CMA; Rodenburg, IL; van der Klauw, MM; van Ginkel, WG; van Spronsen, FJ; van Vliet, K; Wolffenbuttel, BHR	1
Arning, E; Bottiglieri, T; Gibson, KM; Grompe, M; Harding, CO; Winn, SR	1

Other Studies

2 other study(ies) available for nitisinone and BH4 Deficiency

Article	Year
Biomarkers of Micronutrients in Regular Follow-Up for Tyrosinemia Type 1 and Phenylketonuria Patients. Nutrients, 2019, Aug-27, Volume: 11, Issue:9 Topics: Adolescent; Adult; Aged; Amino Acids; Biomarkers; Biopterins; Child; Child, Preschool; Cyclohexanones; Diet, Protein-Restricted; Dietary Supplements; Enzyme Inhibitors; Female; Humans; Infant; Male; Micronutrients; Middle Aged; Nitrobenzoates; Nutritional Status; Phenylketonurias; Retrospective Studies; Risk Assessment; Risk Factors; Tyrosinemias; Vitamin B 12 Deficiency; Vitamin D Deficiency; Young Adult	2019
Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU). Journal of inherited metabolic disease, 2014, Volume: 37, Issue:5 Topics: Amino Acids; Animals; Brain Chemistry; Cyclohexanones; Dopamine; Enzyme Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurotransmitter Agents; Nitrobenzoates; Phenylketonurias; Tyrosine	2014

Article

Year

Biomarkers of Micronutrients in Regular Follow-Up for Tyrosinemia Type 1 and Phenylketonuria Patients.

Nutrients, 2019, Aug-27, Volume: 11, Issue:9

Topics: Adolescent; Adult; Aged; Amino Acids; Biomarkers; Biopterins; Child; Child, Preschool; Cyclohexanones; Diet, Protein-Restricted; Dietary Supplements; Enzyme Inhibitors; Female; Humans; Infant; Male; Micronutrients; Middle Aged; Nitrobenzoates; Nutritional Status; Phenylketonurias; Retrospective Studies; Risk Assessment; Risk Factors; Tyrosinemias; Vitamin B 12 Deficiency; Vitamin D Deficiency; Young Adult

2019

Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU).

Journal of inherited metabolic disease, 2014, Volume: 37, Issue:5

Topics: Amino Acids; Animals; Brain Chemistry; Cyclohexanones; Dopamine; Enzyme Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurotransmitter Agents; Nitrobenzoates; Phenylketonurias; Tyrosine

2014